- JP-listed companies
- Fuso Pharmaceutical Industries,Ltd.
- Financials
- Gross margin (%)
Fuso Pharmaceutical Industries,Ltd. (4538)
Market cap
¥19.6B
P/E ratio
13.6x
Fuso Pharmaceutical Industries manufactures injectable medicines like intravenous solutions and kidney dialysis products, while also operating real estate leasing.
| Period End | Gross margin (%) | YoY (%) |
|---|---|---|
| Mar 31, 2026 | 25.7 | -5.96% |
| Mar 31, 2025 | 27.3 | +9.30% |
| Mar 31, 2024 | 25 | -7.27% |
| Mar 31, 2023 | 26.9 | -0.22% |
| Mar 31, 2022 | 27 | -5.78% |
| Mar 31, 2021 | 28.6 | +4.96% |
| Mar 31, 2020 | 27.3 | -6.36% |
| Mar 31, 2019 | 29.1 | +0.82% |
| Mar 31, 2018 | 28.9 | +2.08% |
| Mar 31, 2017 | 28.3 | +3.25% |
| Mar 31, 2016 | 27.4 | -0.70% |
| Mar 31, 2015 | 27.6 |